Detailed descriptions of patient characteristics according to age, menopausal status, race, ER status, PR status, HER2 status, family history, tumor size, histological status, recurrence/survival status, and follow-up status (alive, dead, or lost to follow-up) are listed in Table 1. This evidence concerns the gene PGR and neoplasm.